CNS Curative Technologies develops intranasal nootropic formulation nootropics designed to improve brain wellness innovations and offer brain alternative therapeutics to Parkinson's disease, cognitive decline, Lewybody dementia, Parkinson's disease dementia, and brain aging dementia.
We have manufacture developed these pharmaceutical technologies, and we will be releasing products, and demonstration trials via e-commerce, and in person at our facilities.